POTOMAC, Md.--(BUSINESS WIRE)--PreScience Labs announced today that the U.S. Food and Drug Administration has approved its Investigational New Drug application for Phase I clinical evaluation of 3-bromopyruvate.
Select Embed Format:
Display in slide mode
Include related documents
Include other documents by this user
Full Screen link:
Pages to are hidden for
"PreScience Labs Announced that the FDA Accepts IND Application for Novel Oncology Drug"